Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Suzuken Co ( (JP:9987) ) is now available.
Suzuken Co., Ltd. reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a slight increase in net sales by 0.6% to ¥2,399,952 million. Despite a challenging market environment, the company achieved a significant 18.9% rise in profit attributable to owners of the parent, amounting to ¥34,496 million. The company announced an increase in annual dividends from ¥80.00 to ¥100.00 per share, reflecting its commitment to returning value to shareholders. The financial forecast for the next fiscal year indicates a modest growth in net sales by 2.8%, though a decline in operating and ordinary profits is expected.
The most recent analyst rating on (JP:9987) stock is a Hold with a Yen5730.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. is a company listed on the Tokyo, Nagoya, and Sapporo Stock Exchanges. It operates in the pharmaceutical distribution industry, providing a range of healthcare-related products and services.
Average Trading Volume: 245,345
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen299.3B
Find detailed analytics on 9987 stock on TipRanks’ Stock Analysis page.